1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow CD20-Positive Neoplastic Cells Present: new trials by email Literature Review of CD20-Positive Neoplastic Cells Present trials Research Report on CD20-Positive Neoplastic Cells Present
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein, Autologous Hematopoietic Stem Cell Transplantation, Carmustine - Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 3 | 2017-02-01 | 2020-11-23 |
Burkitt Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1)
DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Infections (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Carmustine (1) · Cytarabine (1) · DOTA-biotin (1) · Etoposide (1) · Indium (1) · Melphalan (1) · Peripheral Blood Stem Cell Transplantation (1) · carmustine, poliferprosan 20 drug combination (1)
Fred Hutchinson Cancer Center (1)
United States (1)
Ajay Gopal (1)
P01CA044991 (1), P30CA015704 (1)